Akanda announces no equity financing until further notice

London, united kingdom--(newsfile corp. - april 15, 2024) - akanda corp. (nasdaq: akan) ("akanda" or the "company"), an international medical cannabis company, previously announced the completion of several public offerings and the sale of its indirectly wholly-owned portuguese subsidiary, rpk biopharma unipessoal, lda ("rpk") now announces its plans to pause any potential equity financings for a thirty (30) day period while the board meets and confers. the company plans to evaluate and pursue strategic investments in international cannabis plant touching markets as well as ancillary technology services.
AKAN Ratings Summary
AKAN Quant Ranking